Cathie Wood Vertex Pharmaceuticals Inc Transaction History

Ark Investment Management LLC

$9.28 Billion
Q1 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ark Investment Management LLC holds 26,344 shares of VRTX stock, worth $11.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

26,344

Previous 25,350 3.92%

Holding current value

$11.8 Million

Previous $10.2 Million 25.12%

% of portfolio

0.14%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$402.49 - $513.76 $400,075 - $510,677	994 Added 3.92%	26,344 $12.8 Million
Q4 2024 Feb 04, 2025	SELL	$396.64 - $516.74 $10.2 Million - $13.3 Million	-25,749 Reduced 50.39%	25,350 $10.2 Million
Q3 2024 Oct 31, 2024	SELL	$460.0 - $505.78 $11.2 Million - $12.3 Million	-24,365 Reduced 32.29%	51,099 $23.8 Million
Q2 2024 Jul 26, 2024	SELL	$392.81 - $485.53 $5.75 Million - $7.11 Million	-14,640 Reduced 16.25%	75,464 $35.4 Million
Q1 2024 Apr 18, 2024	SELL	$407.69 - $446.08 $13.9 Million - $15.2 Million	-34,093 Reduced 27.45%	90,104 $37.7 Million
Q4 2023 Jan 17, 2024	BUY	$343.0 - $410.68 $3.04 Million - $3.64 Million	8,866 Added 7.69%	124,197 $50.5 Million
Q3 2023 Oct 18, 2023	SELL	$338.18 - $362.46 $114,981 - $123,236	-340 Reduced 0.29%	115,331 $40.1 Million
Q2 2023 Jul 10, 2023	SELL	$314.42 - $351.91 $1.52 Million - $1.7 Million	-4,838 Reduced 4.01%	115,671 $40.7 Million
Q1 2023 Apr 17, 2023	SELL	$283.23 - $323.1 $478,092 - $545,392	-1,688 Reduced 1.38%	120,509 $38 Million
Q4 2022 Jan 24, 2023	SELL	$285.76 - $321.48 $10.1 Million - $11.3 Million	-35,248 Reduced 22.39%	122,197 $0
Q3 2022 Oct 17, 2022	SELL	$273.83 - $305.53 $57 Million - $63.6 Million	-208,077 Reduced 56.93%	157,445 $45.6 Million
Q2 2022 Jul 11, 2022	SELL	$234.96 - $292.55 $13.2 Million - $16.5 Million	-56,253 Reduced 13.34%	365,522 $98.2 Million
Q1 2022 Apr 19, 2022	SELL	$221.42 - $260.97 $112 Million - $132 Million	-507,016 Reduced 54.59%	421,775 $110 Million
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $138 Million - $175 Million	-780,960 Reduced 45.68%	928,791 $204 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $11.7 Million - $13.1 Million	-64,315 Reduced 3.63%	1,709,751 $310 Million
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $10.3 Million - $12.2 Million	55,020 Added 3.2%	1,774,066 $358 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $187 Million - $218 Million	902,852 Added 110.62%	1,719,046 $369 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $149 Million - $198 Million	718,842 Added 738.39%	816,194 $193 Million
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $24.9 Million - $29.5 Million	97,352 New	97,352 $26.5 Million

Others Institutions Holding VRTX

# of Institutions

1,832

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $115B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account